PTX 2.50% 3.9¢ prescient therapeutics limited

Ann: Encouraging Pre-Clinical Data Presented at US Cancer Meeting, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,847 Posts.
    lightbulb Created with Sketch. 18
    PTX-100 reduced multiple myeloma tumours AND sensitised multiple myeloma cells in mice models.

    Should see buyers return to the stock as the data is presented today at the Cancer Research Meeting.

    EV value of $2M is absurd given the trials both pending and underway.

    Even at 16c the stock would still be cheap compared to its ASX peers.

    Cheers.

    .
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.0¢ 3.9¢ $3.806K 96.37K

Buyers (Bids)

No. Vol. Price($)
5 172911 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 19248 1
View Market Depth
Last trade - 14.46pm 20/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.